Influencing the activity of somatic comorbidities through trauma-centered psychotherapy with EMDR using autoimmune thyroiditis Hashimoto, chronic polyarthritis, and inflammatory bowel disease as examples

Influencing the activity of somatic comorbidities through trauma-centered psychotherapy with EMDR using autoimmune thyroiditis Hashimoto, chronic polyarthritis, and inflammatory bowel disease as examples - TP-autoimmun

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00032020

Enrollment

Registered

2023-06-09

Start date

2027-07-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F43.1

Interventions

Group 1: Eye Movement Densensitization and Reprocessing (EMDR) + treatment as usual Group 2: treatment as usual

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: complex posttraumatic disorder, indication for EMDR therapy ATH, CED, RA

Exclusion criteria

Exclusion criteria: Lack of stability and real-life conflicts in the present suicidal patients Patients with acute substance dependence and a schizophrenic disorder or psychotic depression Exclusion criteria for an MRI examination Pregnancy

Design outcomes

Primary

Measure	Time frame
Autoimmune and inflammatory activity of comorbidities autoimmune thyroiditis Hashimoto's, inflammatory bowel disease and / or rheumatoid arthritis	—

Secondary

Measure	Time frame
trauma symptoms measured using the CAPS-5 brain connectivity and activity	—

Countries

Germany

Contacts

Public ContactThomas Frodl

Universitätsklinikum Aachen, RWTH Universität Aachen

tfrodl@ukaachen.de+49 241 80 89632

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026